Mountain Valley MD Holdings Inc. (MVMD.CN) Research

Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., functions as a health and wellness enterprise. The company focuses on deploying and licensing its proprietary innovations to external entities within the pharmaceutical, vaccine, and nutritional supplement sectors. Its portfolio encompasses Quicksome, an advanced technology for oral drug formulation and delivery; Quicksol, designed for enhancing solubility; and a dose-sparing adjuvant. Additionally, the firm is actively developing IM032, a compound currently being evaluated in male beagle dogs to assess intramuscular versus subcutaneous administration methods. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.

Market snapshot

Symbol
MVMD.CN
Price
$0.07
Day change
-6.67%
Market cap
$24.7M
P/E ratio
-3.43x
52-week range
0.01-0.105
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aptose Biosciences Inc. (APS.TO)
  • Avricore Health Inc. (AVCR.V)
  • Avant Brands Inc. (AVNT.TO)
  • Ayurcann Holdings Corp. (AYUR.CN)
  • CanadaBis Capital Inc. (CANB.V)
  • Kane Biotech Inc. (KNE.V)
  • Mercanto Holdings Inc. (MUSH.V)
  • Revive Therapeutics Ltd. (RVV.CN)

Open Mountain Valley MD Holdings Inc. (MVMD.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.